Global Pertussis Vaccine
Market Report
2025
Pertussis Vaccine Market Report 2025 (Global Edition)
The Global Pertussis Vaccine market was valued at USD 5.06 Billion in 2022 and will reach USD 7.35 Billion by 2030, registering a Compound Annual Growth Rate of 5.47% for the forecast period 2023-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Pertussis Vaccine Market Report 2024.
Global Pertussis Vaccine Market Report 2024 Market Size Split by Product Type (Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (Tdap), Other ...
As per Cognitive Market Research's latest published report, The Global Pertussis Vaccine market was valued at USD 5.06 Billion in 2022 and will reach USD 7.35 Billion by 2030, registering a Compound Annual Growth Rate of 5.47% for the forecast period 2023-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Pertussis Vaccine Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.47% |
| Market Split by Product Type |
|
| Market Split by End-User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Pertussis Vaccine industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Pertussis Vaccine Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Pertussis Vaccine Market Report Description
Introduction of Pertussis Vaccine Market
Pertussis is a respiratory disease, usually known as whooping cough, is caused by the bacteria Bordetella pertussis. The major way that pertussis transmits from one person to another is by coughing or sneezing droplets. Infants are especially vulnerable to the disease and it is a major cause of illness and mortality in this age range. Whooping cough is typically treated with the pertussis vaccine. The pertussis vaccine encompasses two main types: whole-cell vaccines and acellular vaccines. This vaccination is only accessible when combined with other immunizations. The Pertussis Vaccine is the most reliable and economical means of maintaining a pertussis-free environment. The World Health Organization has included the tetanus vaccine on the list of essential medicines because it has helped reduce the prevalence of tetanus in the US by 95% since it was first introduced in 1924.
Pertussis Vaccine Market Size
The Driving Factor of the Pertussis Vaccine Market
- Increasing prevalence of pertussis
Rising prevalence of pertussis globally is expected to drive the market growth over the forecasted period. As per the WHO, over 151,000 pertussis cases were reported worldwide in 2018 and 86% of the worldwide target population received the recommended three doses of the DTP-containing vaccination during infancy as of 2018. Thus, the rising number of pertussis infections across the globe is propelling the growth of the pertussis vaccine market.
- The increase in strategic activities by key market players
In order to introduce new goods, major market players are using strategies including partnerships and collaborations; this is anticipated to propel the pertussis vaccine market throughout the course of the projected year. For instance, in June 2021, the French multinational pharmaceutical and healthcare firm Sanofi announced a partnership with the American multinational pharmaceutical business Merck & Co., Inc. to produce vaccines for diseases including Tetanus and diphtheria.
The Restraining Factor of Pertussis Vaccine Market
-
High cost associated with vaccine developments
The high cost of vaccine development and inadequate access to vaccines in developing countries is the main factor hampering the market growth. For instance, as per the Centers for Disease Control and Prevention (CDC) in July 2023, the cost of Quadracel, a DTaP-IPV vaccine manufactured by Sanofi Pasteur, a vaccines division of the French multinational pharmaceutical company Sanofi, is US$ 61.12 for a single vial. Additionally, new markets provide the captivating potential for the major industry participants in the pertussis vaccine market.
Impact of the COVID-19 pandemic on the Pertussis Vaccine Market:
Since December 2019, the COVID-19 virus pandemic has spread to more than 100 nations, and on January 30, 2020, the World Health Organization proclaimed it to be a public health emergency.
COVID-19 has influenced the economy in three key ways which caused a direct impact on medication, vaccine demand and production, interruptions in the distribution channel, and financial impact on businesses and financial markets. In various nations, including China, India, Saudi Arabia, Egypt, the United Arab Emirates, and others, the transit of medicines and vaccinations from one location to another was challenging due to countrywide lockdowns. Quarantine, travel restrictions and social distancing policies are anticipated to cause a sharp fall in consumer and company expenditure. Additionally, hospitalization delays occurred as fewer patients visited the hospital, which was anticipated to have an impact on the worldwide market for pertussis vaccine.
We have various report editions of Pertussis Vaccine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Analysis of the Pertussis Vaccine Market:
Company Recent Developments:
BIONET-ASIA, a vaccine manufacturing company, announced that they entered into a partnership with Pharmaniaga Berhad, a Malaysian pharmaceutical company to the development of a 6-in-1 Hexavalent Vaccine. The vaccine will provide Malaysian medical professionals the opportunity to immunize children against six childhood diseases, including poliomyelitis (IPV), hepatitis B (Hep-B), diphtheria (DT), tetanus (TT), pertussis (aP), and Haemophilus influenza type b (Hib).
The company has substantially strengthened its R&D performance and productivity. New GSK stated to prioritise R&D and commercial investment in vaccines and specialty medicines, which are expected to grow to around three-quarters of company sales by 2026.
Top Companies Market Share in Pertussis Vaccine Industry: (In no particular order of Rank)
- Protein Sciences Corporation
- GlaxoSmithKline
- Sanofi Pasteur
- Seqirus
- Merck Sharp & Dohme Corp.
- Novartis AG
- Astellas Pharma US Inc.
- Bionet-Asia
- Johnson & Johnson
- Massbiologics
- Meiji Holdings Co. Ltd.
- Panacea Biotec Ltd.
- Serum Institute of India Pvt. Ltd.
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
The North American Pertussis Vaccine Market dominates the largest share of the global market
Based on region, the market is classified into North America, Europe, Asia Pacific, Latin America, and Middle East, and Africa. Due to the growing geriatric population and rising pertussis fatality rate, North America largely dominates the pertussis vaccine market. However, due to the rapid population expansion, rising vaccination rates, and rising incidence of infectious diseases, Asia Pacific region is expected to expand at a faster rate.
The current report Scope analyzes Pertussis Vaccine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Pertussis Vaccine Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Pertussis Vaccine Market Analysis
Global Pertussis Vaccine Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Pertussis Vaccine Industry growth. Pertussis Vaccine market has been segmented with the help of its Product Type, End-User , and others. Pertussis Vaccine market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By Product Type, Diphtheria, Tetanus, and Pertussis (DTaP) was the leading category of Pertussis Vaccine market
Based on the product type, the market is divided into Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (Tdap), and other vaccines. The DTaP segment has the most market share and is anticipated to grow at the highest rate over the next few years. The growing need for Dtap vaccines and the entry of important companies along with research and development laboratories are the factors that are fueling the demand for this sector.
- Diphtheria, Tetanus, and Pertussis (DTaP)
- Diphtheria and Tetanus (DT)
- Tetanus, Diphtheria, and Pertussis (Tdap)
- Other Vaccines
Pertussis Vaccine Market Share (%) by Product Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Pertussis Vaccine Industry. Request a Free Sample PDF!
By End-User, Vaccination Center was the leading category of Pertussis Vaccine market
The market for pertussis vaccines is divided into hospitals, clinics, and vaccination centers based on the end user. The vaccination center segment has the biggest market share and is anticipated to grow at the highest CAGR during the projected period. The increase in individuals visiting vaccination centers for vaccinations is the key factor that may be driving the growth of the segment.
- Hospitals
- Clinics
- Vaccination Center
Pertussis Vaccine Market Share (%) by End-User in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Pertussis Vaccine Market is witnessing significant growth in the near future.
In 2023, the Diphtheria segment accounted for noticeable share of global Pertussis Vaccine Market and is projected to experience significant growth in the near future.
The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Protein Sciences Corporation , Sanofi Pasteur and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Pertussis Vaccine Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Pertussis Vaccine Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product Type | Diphtheria, Tetanus, and Pertussis (DTaP), Diphtheria and Tetanus (DT), Tetanus, Diphtheria, and Pertussis (Tdap), Other Vaccines |
| End-User | Hospitals, Clinics, Vaccination Center |
| List of Competitors | Protein Sciences Corporation, GlaxoSmithKline, Sanofi Pasteur, Seqirus, Merck Sharp & Dohme Corp., Novartis AG, Astellas Pharma US Inc., Bionet-Asia, Johnson & Johnson, Massbiologics, Meiji Holdings Co. Ltd., Panacea Biotec Ltd., Serum Institute of India Pvt. Ltd. |
This chapter will help you gain GLOBAL Market Analysis of Pertussis Vaccine. Further deep in this chapter, you will be able to review Global Pertussis Vaccine Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Pertussis Vaccine Revenue Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Pertussis Vaccine Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Pertussis Vaccine Revenue Market Size By Region
-
-
1.3 Global Pertussis Vaccine Market Size By Product Type 2019 -2031
-
1.3.1 Diphtheria Market Size
-
1.3.2 Tetanus Market Size
-
1.3.3 and Pertussis (DTaP) Market Size
-
1.3.4 Diphtheria and Tetanus (DT) Market Size
-
1.3.5 Tetanus Market Size
-
1.3.6 Diphtheria Market Size
-
1.3.7 and Pertussis (Tdap) Market Size
-
1.3.8 Other Vaccines Market Size
-
-
1.4 Global Pertussis Vaccine Market Size By End-User 2019 -2031
-
1.4.1 Hospitals Market Size
-
1.4.2 Clinics Market Size
-
1.4.3 Vaccination Center Market Size
-
-
1.5 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.6 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.6.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.6.2 Global Market Revenue Split By Product Type
-
1.6.3 Global Market Revenue Split By End-User
-
1.6.4 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
This chapter will help you gain North America Market Analysis of Pertussis Vaccine. Further deep in this chapter, you will be able to review North America Pertussis Vaccine Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
-
2.1 North America Pertussis Vaccine Market Size 2019 - 2031
-
2.1.1 North America Pertussis Vaccine Market Size By Country 2019 - 2031
-
2.1.2 North America Pertussis Vaccine Market Size by Product Type 2019 -2031
-
2.1.2.1 North America Diphtheria Market Size
-
2.1.2.2 North America Tetanus Market Size
-
2.1.2.3 North America and Pertussis (DTaP) Market Size
-
2.1.2.4 North America Diphtheria and Tetanus (DT) Market Size
-
2.1.2.5 North America Tetanus Market Size
-
2.1.2.6 North America Diphtheria Market Size
-
2.1.2.7 North America and Pertussis (Tdap) Market Size
-
2.1.2.8 North America Other Vaccines Market Size
-
-
2.1.3 North America Pertussis Vaccine Market Size by End-User 2019 -2031
-
2.1.3.1 North America Hospitals Market Size
-
2.1.3.2 North America Clinics Market Size
-
2.1.3.3 North America Vaccination Center Market Size
-
-
This chapter will help you gain Europe Market Analysis of Pertussis Vaccine. Further deep in this chapter, you will be able to review Europe Pertussis Vaccine Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
-
3.1 Europe Pertussis Vaccine Market Size 2019 - 2031
-
3.1.1 Europe Pertussis Vaccine Market Size By Country 2019 - 2031
-
3.1.2 Europe Pertussis Vaccine Market Size by Product Type 2019 -2031
-
3.1.2.1 Europe Diphtheria Market Size
-
3.1.2.2 Europe Tetanus Market Size
-
3.1.2.3 Europe and Pertussis (DTaP) Market Size
-
3.1.2.4 Europe Diphtheria and Tetanus (DT) Market Size
-
3.1.2.5 Europe Tetanus Market Size
-
3.1.2.6 Europe Diphtheria Market Size
-
3.1.2.7 Europe and Pertussis (Tdap) Market Size
-
3.1.2.8 Europe Other Vaccines Market Size
-
-
3.1.3 Europe Pertussis Vaccine Market Size by End-User 2019 -2031
-
3.1.3.1 Europe Hospitals Market Size
-
3.1.3.2 Europe Clinics Market Size
-
3.1.3.3 Europe Vaccination Center Market Size
-
-
This chapter will help you gain Asia Pacific Market Analysis of Pertussis Vaccine. Further deep in this chapter, you will be able to review Asia Pacific Pertussis Vaccine Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Pertussis Vaccine Market Size 2019 - 2031
-
4.1.1 Asia Pacific Pertussis Vaccine Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Pertussis Vaccine Market Size by Product Type 2019 -2031
-
4.1.2.1 Asia Pacific Diphtheria Market Size
-
4.1.2.2 Asia Pacific Tetanus Market Size
-
4.1.2.3 Asia Pacific and Pertussis (DTaP) Market Size
-
4.1.2.4 Asia Pacific Diphtheria and Tetanus (DT) Market Size
-
4.1.2.5 Asia Pacific Tetanus Market Size
-
4.1.2.6 Asia Pacific Diphtheria Market Size
-
4.1.2.7 Asia Pacific and Pertussis (Tdap) Market Size
-
4.1.2.8 Asia Pacific Other Vaccines Market Size
-
-
4.1.3 Asia Pacific Pertussis Vaccine Market Size by End-User 2019 -2031
-
4.1.3.1 Asia Pacific Hospitals Market Size
-
4.1.3.2 Asia Pacific Clinics Market Size
-
4.1.3.3 Asia Pacific Vaccination Center Market Size
-
-
This chapter will help you gain South America Market Analysis of Pertussis Vaccine. Further deep in this chapter, you will be able to review South America Pertussis Vaccine Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
-
5.1 South America Pertussis Vaccine Market Size 2019 - 2031
-
5.1.1 South America Pertussis Vaccine Market Size By Country 2019 - 2031
-
5.1.2 South America Pertussis Vaccine Market Size by Product Type 2019 -2031
-
5.1.2.1 South America Diphtheria Market Size
-
5.1.2.2 South America Tetanus Market Size
-
5.1.2.3 South America and Pertussis (DTaP) Market Size
-
5.1.2.4 South America Diphtheria and Tetanus (DT) Market Size
-
5.1.2.5 South America Tetanus Market Size
-
5.1.2.6 South America Diphtheria Market Size
-
5.1.2.7 South America and Pertussis (Tdap) Market Size
-
5.1.2.8 South America Other Vaccines Market Size
-
-
5.1.3 South America Pertussis Vaccine Market Size by End-User 2019 -2031
-
5.1.3.1 South America Hospitals Market Size
-
5.1.3.2 South America Clinics Market Size
-
5.1.3.3 South America Vaccination Center Market Size
-
-
This chapter will help you gain Middle East and Africa Market Analysis of Pertussis Vaccine. Further deep in this chapter, you will be able to review Middle East and Africa Pertussis Vaccine Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Pertussis Vaccine Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Pertussis Vaccine Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Pertussis Vaccine Market Size by Product Type 2019 -2031
-
6.1.2.1 Middle East and Africa Diphtheria Market Size
-
6.1.2.2 Middle East and Africa Tetanus Market Size
-
6.1.2.3 Middle East and Africa and Pertussis (DTaP) Market Size
-
6.1.2.4 Middle East and Africa Diphtheria and Tetanus (DT) Market Size
-
6.1.2.5 Middle East and Africa Tetanus Market Size
-
6.1.2.6 Middle East and Africa Diphtheria Market Size
-
6.1.2.7 Middle East and Africa and Pertussis (Tdap) Market Size
-
6.1.2.8 Middle East and Africa Other Vaccines Market Size
-
-
6.1.3 Middle East and Africa Pertussis Vaccine Market Size by End-User 2019 -2031
-
6.1.3.1 Middle East and Africa Hospitals Market Size
-
6.1.3.2 Middle East and Africa Clinics Market Size
-
6.1.3.3 Middle East and Africa Vaccination Center Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Pertussis Vaccine Market Size by Product Type 2019 -2031
-
7.1.2 Country 1Pertussis Vaccine Market Size by End-User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
This chapter provides an in-depth analysis of the market share among key competitors of Pertussis Vaccine. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Pertussis Vaccine Market Revenue and Share by Key Players
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Protein Sciences Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 GlaxoSmithKline
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Sanofi Pasteur
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Seqirus
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Merck Sharp & Dohme Corp.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Novartis AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Astellas Pharma US Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Bionet-Asia
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Johnson & Johnson
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Massbiologics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Meiji Holdings Co. Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Panacea Biotec Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Serum Institute of India Pvt. Ltd.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Restraints
-
9.3 Market Trends
-
9.4 Market Opportunity
-
9.5 Technological Road Map (Subject to Data Availability)
-
9.6 Product Life Cycle (Subject to Data Availability)
-
9.7 Consumer Preference Analysis
-
9.8 Market Attractiveness Analysis
-
9.9 PESTEL Analysis
-
9.9.1 Political Factors
-
9.9.2 Economic Factors
-
9.9.3 Social Factors
-
9.9.4 Technological Factors
-
9.9.5 Legal Factors
-
9.9.6 Environmental Factors
-
-
9.10 Industrial Chain Analysis (Subject to Data Availability)
-
9.10.1 Industry Chain Analysis
-
9.10.2 Manufacturing Cost Analysis
-
9.10.3 Supply Side Analysis
-
9.10.3.1 Raw Material Analysis
-
9.10.3.2 Raw Material Procurement Analysis
-
9.10.3.3 Raw Material Price Trend Analysis
-
-
-
9.11 Porter’s Five Forces Analysis
-
9.11.1 Bargaining Power of Suppliers
-
9.11.2 Bargaining Power of Buyers
-
9.11.3 Threat of New Entrants
-
9.11.4 Threat of Substitutes
-
9.11.5 Degree of Competition
-
-
9.12 Patent Analysis (Subject to Data Availability)
-
9.13 ESG Analysis
Segmentation Product Type Analysis 2019 -2031, will provide market size split by Product Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Type Analysis 2019 -2031
-
10.1 Diphtheria
-
10.1.1 Global Pertussis Vaccine Revenue Market Size and Share by Diphtheria 2019 -2031
-
-
10.2 Tetanus
-
10.2.1 Global Pertussis Vaccine Revenue Market Size and Share by Tetanus 2019 -2031
-
-
10.3 and Pertussis (DTaP)
-
10.3.1 Global Pertussis Vaccine Revenue Market Size and Share by and Pertussis (DTaP) 2019 -2031
-
-
10.4 Diphtheria and Tetanus (DT)
-
10.4.1 Global Pertussis Vaccine Revenue Market Size and Share by Diphtheria and Tetanus (DT) 2019 -2031
-
-
10.5 Tetanus
-
10.5.1 Global Pertussis Vaccine Revenue Market Size and Share by Tetanus 2019 -2031
-
-
10.6 Diphtheria
-
10.6.1 Global Pertussis Vaccine Revenue Market Size and Share by Diphtheria 2019 -2031
-
-
10.7 and Pertussis (Tdap)
-
10.7.1 Global Pertussis Vaccine Revenue Market Size and Share by and Pertussis (Tdap) 2019 -2031
-
-
10.8 Other Vaccines
-
10.8.1 Global Pertussis Vaccine Revenue Market Size and Share by Other Vaccines 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End-User Analysis 2019 -2031
-
11.1 Hospitals
-
11.1.1 Global Pertussis Vaccine Revenue Market Size and Share by Hospitals 2019 - 2031
-
-
11.2 Clinics
-
11.2.1 Global Pertussis Vaccine Revenue Market Size and Share by Clinics 2019 - 2031
-
-
11.3 Vaccination Center
-
11.3.1 Global Pertussis Vaccine Revenue Market Size and Share by Vaccination Center 2019 - 2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Pertussis Vaccine market
Chapter 12 Research Findings
-
12.1 Key Takeaways
-
12.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
12.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Pertussis Vaccine Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Pertussis Vaccine Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Pertussis Vaccine Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Pertussis Vaccine Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Pertussis Vaccine Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Pertussis Vaccine Market
Key Questions Answered By Pertussis Vaccine Market Report 2024
| Why Diphtheria have a significant impact on Pertussis Vaccine market? |
| What are the key factors affecting the Diphtheria and Tetanus of Pertussis Vaccine Market? |
| What is the CAGR/Growth Rate of Hospitals during the forecast period? |
| By type, which segment accounted for largest share of the global Pertussis Vaccine Market? |
| Which region is expected to dominate the global Pertussis Vaccine Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
